Boltz joins a consortium building a large dataset for zero-shot antibody design
GabriCorso · x · 2026-07-22
The post says that, alongside strong models, high-quality datasets are the most important ingredient in AI4Science. It highlights a new consortium organized by @AAlphaBio, with Boltz joining GSK, Cradle, and Dyno to generate a large dataset for zero-shot antibody design.
Related event: Boltz Bio Joins AI Drug Discovery Data Consortium(4 posts)→
More from Companies & People
- Anthropic employee quits to play WoW forever, and the internet gets it — TAbrodi · 2026-10-27
- YC Winter '27 Applications Close Nov 2: $500K Funding Plus $12M in Tokens and Credits — ycombinator · 2026-10-27
- Every announces Thesis: 2027 conference on what human work looks like after automation — every · 2026-10-27
- Why one Vancouver AI startup is growing in Taiwan and Europe instead of the US — ClearwayLaw · 2026-10-27
- McKinsey: Vertical AI Hits ROI in 6 Months 71% of the Time vs 32% for Horizontal Tools — MartinGTobias · 2026-10-27
- Glean lands on Claude Marketplace, letting Anthropic customers offset committed spend — verrsane · 2026-10-27